1. Home
  2. API vs SLP Comparison

API vs SLP Comparison

Compare API & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agora Inc.

API

Agora Inc.

HOLD

Current Price

$4.14

Market Cap

406.7M

Sector

Technology

ML Signal

HOLD

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$18.28

Market Cap

326.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
API
SLP
Founded
2013
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
406.7M
326.7M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
API
SLP
Price
$4.14
$18.28
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$24.00
AVG Volume (30 Days)
667.1K
365.7K
Earning Date
05-26-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
N/A
$59,577,000.00
Revenue This Year
$13.46
$3.80
Revenue Next Year
$12.87
$5.90
P/E Ratio
$92.30
$70.19
Revenue Growth
N/A
10.52
52 Week Low
$3.14
$11.09
52 Week High
$5.50
$21.01

Technical Indicators

Market Signals
Indicator
API
SLP
Relative Strength Index (RSI) 46.39 68.22
Support Level $3.46 $16.26
Resistance Level $4.94 $19.29
Average True Range (ATR) 0.35 0.70
MACD -0.07 0.16
Stochastic Oscillator 5.61 90.08

Price Performance

Historical Comparison
API
SLP

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: